RaltegravirIn Treatment-Naive Patients with HIV-1 Infection

被引：0
|
作者：
Jamie D. Croxtall
Lesley J. Scott
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2010年 / 70卷
关键词：
Tenofovir; Efavirenz; Virological Failure; Raltegravir; Integrase Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Raltegravir, a first-in-class, oral HIV type-1 (HIV-1) integrase inhibitor, blocks the covalent integration of HIV-1 complementary DNA into the host genome.
引用
收藏
页码：631 / 642
页数：11
相关论文
共 50 条
  • [1] Raltegravir In Treatment-Naive Patients with HIV-1 Infection
    Croxtall, Jamie D.
    Scott, Lesley J.
    DRUGS, 2010, 70 (05) : 631 - 642
  • [2] Human cytomegalovirus infection among treatment-naive HIV-1 infected patients in Ethiopia
    Kiros, Mulugeta
    Geteneh, Alene
    Andualem, Henok
    Alemu, Derbie
    Tesfaye, Abebech
    Tefera, Dessalegne Abeje
    Mihret, Adane
    Alemayehu, Dawit Hailu
    Mulu, Andargachew
    PLOS ONE, 2021, 16 (02):
  • [3] Antiretroviral therapy options for treatment-naive patients with HIV-1
    Hedley, Lucy
    Minton, June
    Wallis, Gabriel
    Waters, Laura
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (08) : C122 - C125
  • [4] Maraviroc for Treatment-Naive Patients with HIV-1 Infection: Is the Glass Half Empty or Half Full?
    Sax, Paul E.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (06): : 797 - 799
  • [5] Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection
    Katlama, C
    Valantin, MA
    Matheron, S
    Coutellier, A
    Calvez, V
    Descamps, D
    Longuet, C
    Bonmarchand, M
    Tubiana, R
    De Sa, M
    Lancar, R
    Agut, H
    Brun-Vezinet, F
    Costagliola, D
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (07) : 525 - +
  • [6] HIV-1 drug resistance in treatment-naive, chronically infected patients in Jamaica
    Barrow, Geoffrey J.
    Hylton-Kong, Tina
    Rodriguez, Nayra
    Yamamura, Yasuhiro
    Figueroa, J. Peter
    ANTIVIRAL THERAPY, 2013, 18 (07) : 941 - 944
  • [7] COST-EFFECTIVENESS OF DOLUTEGRAVIR IN HIV-1 TREATMENT-NAIVE PATIENTS IN RUSSIA
    Piercy, J.
    Jakubanis, R.
    Chounta, V
    Bukin, E.
    Kovalchuk, N.
    Punekar, Y. S.
    Holbrook, T.
    VALUE IN HEALTH, 2017, 20 (09) : A788 - A788
  • [8] Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants
    Bednasz, Cindy J.
    Venuto, Charles S.
    Ma, Qing
    Daar, Eric S.
    Sax, Paul E.
    Fischl, Margaret A.
    Collier, Ann C.
    Smith, Kimberly Y.
    Tierney, Camlin
    Yang, Yang
    Wilding, Gregory E.
    Morse, Gene D.
    THERAPEUTIC DRUG MONITORING, 2017, 39 (06) : 596 - 603
  • [9] Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing
    Song, Y. X.
    Xin, R. L.
    Li, Z. C.
    Yu, H. W.
    Lun, W. H.
    Ye, J.
    Liu, A.
    Li, A. X.
    Li, J. W.
    Ye, J. Z.
    Hao, M. Q.
    Lu, H. Y.
    Sun, L. J.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (03): : 339 - 344
  • [10] Antiretroviral drug resistance among treatment-naive HIV-1 patients in southern Taiwan
    Tseng, F. -C.
    Wang, S. -W.
    Lee, H. -C.
    Ko, N. -Y.
    Wu, C. -J.
    Lin, H. -H.
    Ko, W. -C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E192 - E192
12345